Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Alzheimer's Disease

Free Subscription 13.04.2026 2 Acta Neuropathol 12 Alzheimers Dement 1 Ann Neurol 1 BMC Neurol 2 Brain 1 Curr Alzheimer Res 18 J Alzheimers Dis 1 J Neurochem 1 Nature 1 Neurobiol Aging 1 Neurochem Res 3 Neurology 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. MELIKYAN ZA, Al-Darsani Z, Jiang L, Colcord KA, et al
   Contribution of health history and neuropathologic changes to the likelihood of dementia in those with intermediate/high Alzheimer's pathology: findings from The 90 + Study.
   Acta Neuropathol. 2026;151:36.
   PubMed         Abstract available
   
   
2. HAQ I, Ngo JC, Roy N, Lee E, et al
   Alzheimer's disease risk protein SorLA regulates ER homeostasis and lipid metabolism in human microglia, with conserved effects in neurons.
   Acta Neuropathol. 2026;151:37.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

3. YANG NV, Wang S, Li B, Simms J, et al
   TOMM40 suppression promotes neuronal cholesterol imbalance and molecular and behavioral phenotypes of Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71306.
   PubMed         Abstract available
   
   
4. KARABOVA MK, Del Ser-Badia A, Hedegaard A, Washer SJ, et al
   Tracking tau and cellular responses in human iPSC-microglia: from uptake to seedable secretion, including in extracellular vesicles.
   Alzheimers Dement. 2026;22:e71337.
   PubMed         Abstract available
   
   
5. JUNG DH, Park E, Ju HC, Moon C, et al
   Glial pathology networks reveal early olfactory vulnerability in post mortem human Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71322.
   PubMed         Abstract available
   
   
6. MARRIOTT AE, Schroeder JP, Korukonda A, Pate BS, et al
   Impact of early locus coeruleus lesions in the TgF344 Alzheimer's disease rat model.
   Alzheimers Dement. 2026;22:e71334.
   PubMed         Abstract available
   
   
7. HU M, Knopman DS, Therneau T, Fought AJ, et al
   Breakpoints in Alzheimer's disease biomarkers and cognition across the aging spectrum: The Mayo Clinic Study of Aging.
   Alzheimers Dement. 2026;22:e71227.
   PubMed         Abstract available
   
   
8. BOYD RJ, Dong D, Sagar R, Iliuk A, et al
   Proteomic profiling of brain organoids and extracellular vesicles identifies early Alzheimer's disease biomarkers and drug response heterogeneity.
   Alzheimers Dement. 2026;22:e71273.
   PubMed         Abstract available
   
   
9. LOMBARDO FL, Caraglia N, Lorenzini P, Vanacore N, et al
   Mild cognitive impairment-to-Alzheimer's dementia progression risk: the contribution of the Interceptor project.
   Alzheimers Dement. 2026;22:e71204.
   PubMed         Abstract available
   
   
10. KANWAL A, Kerman BE, Wang S, Camey K, et al
    A perspective: PLA2G4A as drug target for vascular inflammation in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71320.
    PubMed         Abstract available
    
    
11. ROBB WH, Kaur G, Huang S, Martinez F, et al
    Health system patterns of imaging and fluid biomarker testing in the era of anti-amyloid therapies.
    Alzheimers Dement. 2026;22:e71343.
    PubMed         Abstract available
    
    
12. 
    Correction to "Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: A multicenter real-world study".
    Alzheimers Dement. 2026;22:e71347.
    PubMed        
    
    
13. SWIFT SK, Huang G, Cochran JN, D'Oliveira Albanus R, et al
    Integrative genomic and functional analyses reveal NINL as a modulator of tau aggregation.
    Alzheimers Dement. 2026;22:e71352.
    PubMed         Abstract available
    
    
14. BORELLI PV, Machado L, Carello-Collar G, Ferreira PCL, et al
    Diagnostic performance of salivary markers of Alzheimer's disease: A systematic review.
    Alzheimers Dement. 2026;22:e71248.
    PubMed         Abstract available
    
    

    
    Ann Neurol

15. YOUSSEF H, Gatto RG, Ghayal NB, Estades Ayuso V, et al
    Biochemical and Immunohistochemical Associations of TDP-43 and Cryptic RNA With Hippocampal and Amygdala Volumetrics in Alzheimer's Disease.
    Ann Neurol. 2026 Apr 8. doi: 10.1002/ana.78223.
    PubMed         Abstract available
    
    

    
    BMC Neurol

16. KOUASSI KL, Ehoulan FREA, Beuseize AMR, Broh NYC, et al
    Epidemiologic and clinical features of Alzheimer's disease: a hospital study based on the memory clinic in Abidjan, Cote D'ivoire, Sub-Saharan Africa.
    BMC Neurol. 2026 Apr 7. doi: 10.1186/s12883-026-04867.
    PubMed        
    
    

    
    Brain

17. WATANABE H, Whitwell JL, Bhaskaran JG, Lowe VJ, et al
    Imposter in the brain: aetiological, clinical and neuroimaging characteristics of Capgras syndrome.
    Brain. 2026;149:1224-1238.
    PubMed         Abstract available
    
    
18. BENINA N, Buitrago L, De Simone FI, Radwan RR, et al
    Plasma pTau 217/beta-amyloid 1-42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology.
    Brain. 2026;149:1168-1181.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

19. OZCAN F
    Voice Biomarkers: Cognitive Impairment, including Alzheimer's Disease, Dementia, or Mild Cognitive Impairment: Introduction to Peripheral Neuropathy.
    Curr Alzheimer Res. 2026 Apr 6. doi: 10.2174/0115672050454281260307134058.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

20. PATEL H, Choi A, Weng P, Karl J, et al
    Cerebrospinal fluid amyloid-beta 42/40 ratio is associated with ganglion cell-inner plexiform layer thinning in individuals with and without amyloid pathology.
    J Alzheimers Dis. 2026;110:1438-1446.
    PubMed         Abstract available
    
    
21. PROULX D, Kirk A, O'Connell M, Morgan D, et al
    Does anticholinergic medication use on presentation to a rural memory clinic predict cognitive or functional decline over one year?
    J Alzheimers Dis. 2026;110:1490-1495.
    PubMed         Abstract available
    
    
22. THACKER A, Parks AL, Dohan D, Ramirez Gomez LA, et al
    A qualitative study investigating clinician experiences with lecanemab implementation across seven academic medical centers.
    J Alzheimers Dis. 2026;110:1265-1281.
    PubMed         Abstract available
    
    
23. NEUGROSCHL J, Sewell M, Zhu C, Dauray A, et al
    Reporting of high-risk groups in research in U.S. dementia clinical trials: A systematic review.
    J Alzheimers Dis. 2026;110:1065-1071.
    PubMed         Abstract available
    
    
24. GOGOLA A, Cohen AD, Lopresti BJ, Ikonomovic MD, et al
    Plasma amyloid-beta predicts amyloid-beta accumulation in PET A- non-demented participants.
    J Alzheimers Dis. 2026;110:1166-1174.
    PubMed         Abstract available
    
    
25. TAYEM AJ, Jaber AB, Altantawi AM, Masadeh NM, et al
    Increased vulnerability to low-density lipoprotein cholesterol in apolipoprotein E4-positive females: Longitudinal effects on neurodegeneration and cognition.
    J Alzheimers Dis. 2026;110:1214-1224.
    PubMed         Abstract available
    
    
26. CHEN Y, Zhao S, Yang F, Wang Y, et al
    The interventional effect of acupuncture on overall cognitive function in Alzheimer's disease spectrum disorders: A meta-analysis.
    J Alzheimers Dis. 2026 Apr 8:13872877261438495. doi: 10.1177/13872877261438495.
    PubMed         Abstract available
    
    
27. HEMMY L, Cevasco-Trotter A, Silverman M, Wang S, et al
    Music therapy interest in patients with Alzheimer's disease and Alzheimer's disease related dementia: A survey study.
    J Alzheimers Dis. 2026 Apr 7:13872877261437271. doi: 10.1177/13872877261437271.
    PubMed         Abstract available
    
    
28. SHARIF-ASKARI Z, Atoui K, El Zein W, Rizk M, et al
    From periodontitis to neurodegeneration: Can probiotics modulate the P. gingivalis-amyloid pathway in Alzheimer's disease?
    J Alzheimers Dis. 2026 Apr 6:13872877261432686. doi: 10.1177/13872877261432686.
    PubMed         Abstract available
    
    
29. GEDA YE, Krell-Roesch J, Bekele K, Gunning JA, et al
    Time-restricted eating in Alzheimer's disease (TREAD): A call for research.
    J Alzheimers Dis. 2026 Apr 6:13872877261438520. doi: 10.1177/13872877261438520.
    PubMed         Abstract available
    
    
30. LIU M, Bhatt K, Giaever MF, Ardekani BA, et al
    Sex differences in cognitive performance in Alzheimer's disease: Insights from the ADAS-Cog-13.
    J Alzheimers Dis. 2026 Apr 6:13872877261440125. doi: 10.1177/13872877261440125.
    PubMed         Abstract available
    
    
31. DE LEVANTE RAPHAEL D
    Persistent functional impairment as a preclinical signal of Alzheimer's disease: Advancing dementia prognostication through the natural history of function.
    J Alzheimers Dis. 2026 Apr 6:13872877261438521. doi: 10.1177/13872877261438521.
    PubMed         Abstract available
    
    
32. COSTA T, Liloia D, Premi E, Ashton N, et al
    A Bayesian classification model for differential diagnosis of Alzheimer's disease and frontotemporal dementia using plasma biomarkers.
    J Alzheimers Dis. 2026 Apr 6:13872877261439950. doi: 10.1177/13872877261439950.
    PubMed         Abstract available
    
    
33. GU Q, Xie Y, Zhao Z, Zhuang Z, et al
    CeRNA regulatory network of cerebral microvascular dysfunction in early development of APP/PS1 mice model of Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 6:13872877261435563. doi: 10.1177/13872877261435563.
    PubMed         Abstract available
    
    
34. ZOU H, Wang T, Huynh K, Meikle PJ, et al
    Plasma lipid trajectories improve prediction of future Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 6:13872877261435212. doi: 10.1177/13872877261435212.
    PubMed         Abstract available
    
    
35. DING K, Jiang W, Lei M, Gao Y, et al
    Uncovering polygenic and local genetic overlap between sarcopenia and Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 6:13872877261436016. doi: 10.1177/13872877261436016.
    PubMed         Abstract available
    
    
36. HAYAKAWA N, Takeda S, Takahashi H, Arisawa A, et al
    Distinct patterns of microstructural brain changes in Alzheimer's disease subtypes: Diffusion MRI metrics in braak stage-related regions.
    J Alzheimers Dis. 2026 Apr 6:13872877261436754. doi: 10.1177/13872877261436754.
    PubMed         Abstract available
    
    
37. HOILUND-CARLSEN PF, Alavi A, Costa T, Neve RL, et al
    Serious doubts about amyloid-beta (Abeta) biomarkers and anti-Abeta immunotherapy.
    J Alzheimers Dis. 2026;110:1079-1084.
    PubMed         Abstract available
    
    

    
    J Neurochem

38. PAIDI RK, Gorai S, Mondal S, Pahan K, et al
    L-Leucine Upregulates Lysosomal Biogenesis and Autophagy to Lower Plaques in 5XFAD Mouse Model of Alzheimer's Disease.
    J Neurochem. 2026;170:e70432.
    PubMed         Abstract available
    
    

    
    Nature

39. ZHANG J, Liu Z
    Don't rush use of lymphatic surgery in Alzheimer's disease.
    Nature. 2026;652:534.
    PubMed        
    
    

    
    Neurobiol Aging

40. ZHU Y, Lan G, Li A, Zhang L, et al
    Association of plasma glial fibrillary acidic protein and APOE-epsilon4 with Alzheimer's disease.
    Neurobiol Aging. 2026;164:19-27.
    PubMed         Abstract available
    
    

    
    Neurochem Res

41. RIAZ M, Qadir H, Noman M, Ahmed S, et al
    Mechanistic Insights into Bergapten by Modulation of Filamin A and GSK3beta in STZ Induced Alzheimer's Disease: An Integrated In Silico, In Vitro and In Vivo Study.
    Neurochem Res. 2026;51:133.
    PubMed        
    
    

    
    Neurology

42. PARK SY, Setiawan VW, Crimmins EM, White LR, et al
    Plant-Based Dietary Patterns and Risk of Alzheimer Disease and Related Dementias in the Multiethnic Cohort Study.
    Neurology. 2026;106:e214916.
    PubMed         Abstract available
    
    
43. LLIBRE-GUERRA JJ, Lu R, Clarens MF, Liu I, et al
    Effect of Cognitive Reserve on Age at Symptom Onset and Cognitive Decline in Individuals With Dominantly Inherited Alzheimer Disease.
    Neurology. 2026;106:e214804.
    PubMed         Abstract available
    
    
44. JUNG J
    Cognitive Reserve in Genetic Alzheimer Disease: Why the Brain's "Buffer" Matters More Than We Thought.
    Neurology. 2026;106:e214887.
    PubMed        
    
    

    
    PLoS One

45. GONZALES M, Kang X, Cort C, Adamson MM, et al
    White matter microstructure disruption associated with PET and cognitive impairment in Alzheimer's disease.
    PLoS One. 2026;21:e0346661.
    PubMed         Abstract available
    
    
46. 
    Correction: Exploring emotion recognition in patients with mild cognitive impairment and Alzheimer's dementia undergoing a rehabilitation program emotion recognition in patients with dementia.
    PLoS One. 2026;21:e0346658.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

47. COLWELL CS
    Timing the decline: Cellular circadian rhythms and Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2026;123:e2604049123.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum